Single cardiac troponin T measurement predicts risk for adverse outcome in decompensated heart failure;Dosagem única de troponina cardíaca T prediz risco adverso na insuficiência cardíaca descompensada

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 4, 2010, Pages 495-501

  Oliveira, Manoel D C ^a,b,c,d   Álvares, Juliana ^d   Moreira, Maria Consolação V ^d  

^a HOSPITAL FELÍCIO ROCHO   (Brazil)

^b Odilon Behrens Hospital   (Brazil)

^c FUNDAÇÃO HOSPITALAR DO ESTADO DE MINAS GERAIS   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Heart failure; Prognostic; Troponin T administration dosage

Indexed keywords

TROPONIN T;

ADULT; ADVERSE OUTCOME; ARTICLE; CONTROLLED STUDY; DECOMPENSATED HEART FAILURE; FEMALE; HEART FAILURE; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SURVIVAL;

EID: 77953141757     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Narula J, Haider N, Virman R, DiSalvo TG, Kolodgie FD, Hajjar RD, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996; 335: 1182-1189
2. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara J, et al. Apoptosis in the failing human heart. N Engl J Med. 1997; 336: 1131-1141
3. Antman ME, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996; 335: 1342-1349
4. Lindahl B, Toss H, Siegbahn A, Venge P, Walletin L (for the FRISC-study group). Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000; 343: 1139-1147
5. Missov E, Mair J. A novel biochemical approach to congestive heart failure: Cardiac Troponin T. Am Heart J. 1999; 138: 95-99 (Pubitemid 29331127)
6. Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A, et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol. 1999; 84 (5): 608-11, A9.
7. La Vecchia L, Mezzena G, Ometto R, Finocchi G, Bedogni F, Soffiati G, et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol. 1997; 80 (1): 88-90. (Pubitemid 27274588)
8. Horwich T, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction and increased mortality rates in advanced heart failure. Circulation. 2003; 108: 833-838 (Pubitemid 37022125)
9. Missov E, Calzolari C, Bernard P. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 1997; 96: 2953-2958 (Pubitemid 27500095)
10. Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 2001; 103: 369-374 (Pubitemid 32105975)
11. Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselbland V, Holleman CM, et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J. 2004; 147 (3): 546-552 (Pubitemid 38880881)
12. Perna ER, Macín SM, Canella JPC, Augier N, Stival RLJ, Cialzeta JR, et al . Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation. 2004; 110: 2376-2382 (Pubitemid 39407342)
13. La Vecchia L, Mezzena G, Zanolla L, Paccanaro M, Varotto L, Bonanno C, et al . Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant. 2000; 19 (7): 644-652
14. Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol. 2002; 15 (89): 691-695
15. Del Carlo CH, Pereira-Barreto AC, Cassaro-Strunz C, Latorre MRDO, Ramires JAF. Serial measure of cardiac troponin T levels for prediction of clinical events in acute decompensated heart failure. J Card Fail. 2004; 10 (1): 43-48
16. Perna ER, Macín SM, Canella JPC, Alvarenga PM, Rios NG, Pantich R, et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol. 2005; 99 (2): 253-261
17. Perna ER, Macín SM, Canella JPC, Alvarenga PM, Pantich RE, Ríos NG, et al. High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure. Med Sci Monit. 2004; 10 (3): 90-95
18. Ralli S, Horwirch TB, Fonarow GC. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure. Am Heart J. 2005; 150: 1220-1227
19. You JJ, Austin PC, Alter DA, Ko DT, Tu JV. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J. 2007; 153: 462-470
20. Perna ER, Macín SM, Canella JPC, Szysko A, Franciosi V, Morales WV, et al. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. J Heart Lung Transplant. 2006; 25: 1230-1240
21. Peacock IV FW, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. (ADHERE investigators). Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008; 358 (20): 2117-2126 (Pubitemid 351679598)
22. Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N, et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation. 1988; 77 (3): 607-612 (Pubitemid 18073352)
23. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003; 41: 1797-1804 (Pubitemid 36584255)
24. Drazner MH, Rame EJ, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and third heart sound in patients with heart failure. N Engl J Med. 2001; 345 (8): 574-581
25. Silver MA, Horton DP, Ghali JK, Elkayam U. Effects of nesiritide versus dobutamine on short-term outcome in the treatment of patients with acutely acute decompensated heart failure. J Am Coll Cardiol. 2002; 39 (5): 798-803. (Pubitemid 34185326)
26. Gheorghiade M, Gattis WA, Adams KF, Jaffe A, O'Connor C. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). Am Heart J. 2003; 145 (Suppl 2): S55-S57.
27. Logeart D, Beyne P, Cusson C, Tokmakova M, Leban M, Guiti C, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J. 2001; 141 (2): 247-253 (Pubitemid 32128730)
28. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire D, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006; 113: 1958-1965
29. Del Carlo CH, Pereira-Barreto AC, Cassaro-Strunz CM, Latorre MRDO, de Oliveira Jr MT, Ramires JA. Troponina cardíaca T para estratificação de risco na Insuficiência cardíaca crônica descompensada. Arq Bras Cardiol. 2009; 92 (5): 404-412